Feasibility and compliance of epirubicin plus ambulatory continuous infusion ifosfamide at escalating doses in advanced soft tissue sarcomas: a phase I study

R. Palumbo; S. Toma

doi:10.1016/0959-8049(95)00314-9

Feasibility and compliance of epirubicin plus ambulatory continuous infusion ifosfamide at escalating doses in advanced soft tissue sarcomas: a phase I study

Istituti Clinici Scientifici Maugeri Spa – Società Benefit

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1552-1553
Number of pages	2
Journal	European Journal of Cancer
Volume	31
Issue number	9
DOIs	https://doi.org/10.1016/0959-8049(95)00314-9
Publication status	Published - 1995

ASJC Scopus subject areas

Cancer Research
Oncology
Hematology

Access to Document

10.1016/0959-8049(95)00314-9

Cite this

@article{93be03defb2845c19aa59620b86973af,

title = "Feasibility and compliance of epirubicin plus ambulatory continuous infusion ifosfamide at escalating doses in advanced soft tissue sarcomas: a phase I study",

author = "R. Palumbo and S. Toma",

year = "1995",

doi = "10.1016/0959-8049(95)00314-9",

language = "English",

volume = "31",

pages = "1552--1553",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd",

number = "9",

}

TY - JOUR

T1 - Feasibility and compliance of epirubicin plus ambulatory continuous infusion ifosfamide at escalating doses in advanced soft tissue sarcomas

T2 - a phase I study

AU - Palumbo, R.

AU - Toma, S.

PY - 1995

Y1 - 1995

UR - http://www.scopus.com/inward/record.url?scp=0029091246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029091246&partnerID=8YFLogxK

U2 - 10.1016/0959-8049(95)00314-9

DO - 10.1016/0959-8049(95)00314-9

M3 - Article

C2 - 7577092

AN - SCOPUS:0029091246

VL - 31

SP - 1552

EP - 1553

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 9

ER -